Patel G, et al. - In order to gain clarity regarding in-hospital outcomes of patients with chronic hematologic malignancies (CHM) presenting with ST-segment elevation myocardial infarction (STEMI), researchers used Nationwide Inpatient Sample data (2003-2014) and identified adult patients who presented with a primary diagnosis of STEMI. Chronic myelogenous leukemia, chronic lymphocytic leukemia, essential thrombocythemia, polycythemia vera, chronic monocytic leukemia, and multiple myeloma defined CHM. The final analysis included 2,715,807 STEMI patients; a diagnosis of CHM was seen in 11,974 (0.4%) of them. Based on the findings, similar treatment strategies were recommended in CHM patients presenting with STEMI as are used to treat those without CHM, including revascularization if indicated, because of seemingly sizable outcome advantage with this approach.